Good News – First “Drug Manufacturing License” Secured

We are pleased to announce that SBK has successfully passed the comprehensive review by the Sichuan Medical Products Administration and has been granted the Drug Manufacturing License (Category B) for our chemical Class 1 new drug, SBK002 tablets. This achievement lays the foundation for the company’s future commercial production of innovative drugs and has further advanced our Drug Marketing Authorization Holder (MAH) program.

SBK remains steadfast in its mission to “Empowering Better Health Through Inclusive Care and Support”. We are committed to driving pharmaceutical innovation, rigorously fulfilling our responsibilities as a Marketing Authorization Holder, ensuring the highest standards of drug quality and safety, and continuously strengthening our competitive position. This accomplishment further contributes to the ongoing growth and success of the pharmaceutical industry.